| Category | Product Name | CAS Number | Formula | Assay | Specifications |
| Apixaban | Apixaban | CAS No.503612-47-3 | C25H25N5O4 | 99% | CP, EP, In-house, As Required |
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | CAS No.503614-91-3 | C27H28N4O5 | 98% | / | |
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | CAS No.1267610-26-3 | C15H19N3O2 | 98% | / | |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | CAS No.545445-44-1 | C20H25N3O3 | 98% | / | |
| Ticagrelor | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | CAS No.376608-71-8 | C17H17F2NO3 | 98% | / |
| 4,6-dichloro-2-propylthiopyrimidine-5-amine | CAS No.145783-15-9 | C7H9Cl2N3S | 98% | / | |
| 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3H-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid | CAS No.376608-65-0 | C14H25NO10 | 98% | / | |
| Isopropylidene Ticagrelor | CAS No.274693-26-4 | C26H32F2N6O4S | 98% | / | |
| Ticagrelor | CAS No.274693-27-5 | C23H28F2N6O4S | 98% | CP, EP, In-house, As Required | |
| Semaglutide | Octadecanedioic acid mono-tert butyl ester | CAS No.843666-40-0 | C22H42O4 | 98% | / |
| Semaglutide main chain P29 (N-3) | CAS No.1169630-82-3 | C142H216N38O45 | 50% | / | |
| AEEA-AEEA-OH (Semaglutide Tetrapeptide – side chain intermediate) | CAS No.1143516-05-5 | C12H24N2O7 | 98% | / | |
| Fmoc-AEEA-OH (side chain intermediate) | CAS No.166108-71-0 | C21H23NO6 | 98% | / | |
| tBuO-Ste-γGlu(OtBu)-AEEA-AEEA-OH (side chain intermediate) | CAS No.1118767-15-9 | C47H82N4O15 | 98% | / | |
| AEEA-HCl (side chain intermediate) | CAS No.134979-01-4 | C6H14ClNO4 | 98% | / | |
| Boc-AEEA-OH (side chain intermediate) | CAS No.108466-89-3 | C11H21NO6 | 98% | / | |
| Fmoc-L-Lys[Oct-(OtBu)-Glu-(OtBu)-AEEA-AEEA]-OH (side chain intermediate) | CAS No.1662688-20-1 | C64H101N5O16 | 98% | / | |
| Boc-L-His(Trt)-Aib-OH (N-2 fragment intermediate) | CAS No.2061897-68-3 | C34H38N4O5 | 98% | / | |
| Fmoc-His-Aib-OH (N-2 fragment intermediate) | CAS No.1446013-07-5 | C25H26N4O5 | 98% | / | |
| Semaglutide 98% Oral Grade | CAS No.910463-68-2 | C187H291N45O59 | 98% | CP, EP, In-house, As Required | |
| Semaglutide Crude Product (N-0.5) | CAS No.910463-68-2 | C187H291N45O59 | 98% | In-house | |
| Dapagliflozin | 5-bromo-2-chloro-4′-ethoxydiphenylmethane | CAS No.461432-23-5 | C15H14BrIO | 98% | / |
| 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene | CAS No.1103738-29-9 | C15H14ClIO | 98% | / | |
| Dapagliflozin Tetraacetate | CAS No.461432-25-7 | C29H33ClO10 | 98% | / | |
| Dapagliflozin | CAS No.461432-26-8 | C21H25ClO6 | 99% | CP, EP, In-house, As Required | |
| Empagliflozin | Empagliflozin | CAS No.864070-44-0 | C23H27ClO7 | 98% | CP, EP, In-house, As Required |
| Acetoxy Empagliflozin (Empagliflozin N-1) | CAS No.915095-99-7 | C31H35ClO11 | 98% | / | |
| (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran | CAS No.915095-94-2 | C17H16ClIO2 | 99% | / | |
| (3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one | CAS No.32384-65-9 | C18H42O6Si4 | 98% | / | |
| (3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran | CAS No.915095-89-5 | C17H16BrClO2 | 98% | / | |
| Saxagliptin | Boc-3-Hydroxy-1-adamantyl-D-glycine | CAS No.361442-00-4 | C17H27NO5 | 99% | / |
| Saxagliptin | CAS No.945667-22-1 | C18H27N3O3 | 98% | CP, EP, In-house, As Required | |
| (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | CAS No.361440-67-7 | C11H18N2O3 | 99% | / | |
| Vericiguat | 5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile | CAS No.1350653-26-7 | C14H8F2N4 | 98% | / |
| Vericiguat | CAS No.1350653-20-1 | C19H16F2N8O2 | 98% | CP, EP, As Required | |
| 2-Chloro-5-fluoronicotinonitrile | CAS No.791644-48-9 | C6H2ClFN2 | 98% | / | |
| 1H-Pyrazolo[3,4-b]pyridine, 5-fluoro-3-iodo | CAS No.1350653-23-4 | C6H3FIN3 | 98% | / | |
| 2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine | CAS No.1350653-30-3 | C17H14F2N8 | 98% | / | |
| Rosuvastatin | Rosuvastatin | CAS No.147098-20-2 | C22H30CaFN3O6S | 98% | CP, EP, In-house, As Required |
| (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester | CAS No.154026-94-5 | C13H23ClO4 | 98% | / | |
| tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate | CAS No.154026-95-6 | C15H26O6 | 98% | / | |
| N-(4-(4-fluorophenyl)-5-formyl-6-isopropylpyrimidin-2-yl)-N-methyl-methanesulfonamide | CAS No.147118-37-4 | C16H18FN3O3S | 98% | / | |
| Phosphonium, [[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl] | CAS No.885477-83-8 | C34H34FN3O2PS·Br | 98% | / | |
| N-(5-((diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | CAS No.289042-10-0 | C28H29FN3O3PS | 98% | / | |
| Rosuvastatin intermediate R-2 | CAS No.289042-12-2 | C29H40FN3O6S | 98% | / | |
| tert-Butyl rosuvastatin | CAS No.355806-00-7 | C26H36FN3O6S | 98% | / | |
| Finerenone | Finerenone | CAS No.1050477-31-0 | C21H22N4O3 | 98% | CP, EP, In-house, As Required |
| 4-cyano-2-methoxybenzaldehyde | CAS No.21962-45-8 | C9H7NO2 | 98% | / | |
| L(-)-Epinephrine | Epinephrine Hydrochloride | CAS No.55-31-2 | C9H14ClNO3 | 98% | CP, EP, In-house, As Required |
| Norepinephrine Bitartrate | CAS No.69815-49-2 | C12H19NO10 | 98% | CP, EP, In-house, As Required |
Be the first to get our latest styles and offers.
Building B,No.6 Xingzhi Road,Nanjing Economic and Technological Development Zone
Copyright © 2026 Farmasino Medical Co.,Ltd. All rights reserved. - Privacy Policy
EN
